Legacy Foundation HBO2

Inclusion Criteria

• Patient is currently undergoing treatment for breast cancer and is on one of two pathways:
•     Pathway 1 involves lumpectomy with radiation therapy, recurrence years later, mastectomy and tissue expander with further radiation therapy
•     Pathway 2 involves mastectomy and tissue expander, 6 weeks of radiation therapy, and an implant in 6 months
• Undergone mastectomy with expander or implant reconstruction > 2 weeks before starting radiation therapy
• Completed chest wall irradiation in the past 3 days
• Willing to stop herbal medications as directed by provider
• Willing to stop daily use of supplemental vitamin E (Multivitamin with vitamin E component is acceptable, vitamin E cream is also acceptable)
• Willing to have photographs of chest area taken for research purposes only

Exclusion Criteria

• Have final implant placed < 2 weeks before start of radiation therapy
• Plan to place final impacts < 4 months from the completion of radiation therapy, if tissue expanders are intact during radiation therapy
• Radiation completed more than 3 days prior to study start
• Unwilling or unable to stop oral supplemental Vitamin E

Please contact Legacy Oncology Research for additional study inclusion/exclusion information.